- The Hormel Institute, University of Minnesota
- United States of America
About Luke Hoeppner
Channels contributed to:News and Opinion
Promising work, especially in light of FDA-approved AAV gene therapy entering the U.S. market early this year to restore vision in patients diagnosed with biallelic RPE65-mutation-associated ret...